Relmada Therapeutics, Inc. (RLMD)

Relmada Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Relmada Therapeutics stock has a target of 10, which predicts a 129.89% increase from the current stock price of 4.35.

Price Target: $10 (+129.89%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$10	$10	$10	$10
Change	+129.89%	+129.89%	+129.89%	+129.89%

* Price targets were last updated on Nov 19, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for Relmada Therapeutics is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	1	1	1	1	0	0
Buy	0	0	0	0	1	1
Hold	2	2	2	2	1	0
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	0	0
Total	4	4	4	4	2	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Uy Ear Mizuho	Mizuho	Hold → Buy Upgrades $1 → $10	Hold → Buy	Upgrades	$1 → $10	+129.89%	Nov 19, 2025
Uy Ear Mizuho	Mizuho	Buy → Hold Downgrades $23 → $1	Buy → Hold	Downgrades	$23 → $1	-77.01%	Dec 5, 2024
Marc Goodman Leerink Partners	Leerink Partners	Buy → Hold Downgrades $10 → $1	Buy → Hold	Downgrades	$10 → $1	-77.01%	Dec 4, 2024
Andrew Tsai Jefferies	Jefferies	Hold → Strong Buy Upgrades $3.5 → $13	Hold → Strong Buy	Upgrades	$3.5 → $13	+198.85%	Sep 17, 2024
Andrea Tan Goldman Sachs	Goldman Sachs	Hold → Strong Sell Downgrades $3 → $2	Hold → Strong Sell	Downgrades	$3 → $2	-54.02%	Jun 5, 2024

More Analyst Ratings

Financial Forecast

• Revenue This Year:
  n/a
• Revenue Next Year:
  n/a
• EPS This Year:
  -1.25

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-3.81	-7.16	-5.30	-3.28	-2.65	-1.25	-0.59
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-1.29	-0.61
Avg	-1.25	-0.59
Low	-1.21	-0.57

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.